POINT Biopharma Global Inc

NASDAQ:PNT  
6.48
+0.10 (+1.57%)
Earnings Announcements

POINT Biopharma Posts Qtrly Loss Per Share $0.18

Published: 05/13/2022 12:44 GMT
POINT Biopharma Global Inc (PNT) - Point Biopharma Reports First Quarter 2022 Financial Results and Provides Business Update.
Point Biopharma Global Inc Qtrly Loss per Share $0.18.
Point Biopharma Global Inc - Exisiting Cash and Cash Equivalents, Anticipated to Fund Operations Into Q1 of 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.